Knowledge | Noninvasive Prenatal Testing (NIPT): An Important Step in Prenatal Genetic Screening
Pregnancy often brings many questions and concerns, with the baby’s health among the most important. Noninvasive Prenatal Testing (NIPT) is a simple blood test that screens for potential fetal genetic abnormalities, particularly chromosomal conditions such as Down syndrome. Although widely used, NIPT does not provide a definitive diagnosis, so more medical professionals now call it noninvasive prenatal screening (NIPS).
What Is NIPT?
NIPT is a blood-based test that examines cell-free DNA (cfDNA) in maternal blood. During pregnancy, some of this DNA comes from the fetus and is called cell-free fetal DNA (cffDNA). Scientists analyze these DNA fragments to screen for specific fetal chromosomal abnormalities. Because no invasive procedure is required, the test poses no risk to the pregnant woman or fetus.
What Can NIPT Tell You?
NIPT primarily screens for trisomies, in which a fetus has three copies of a chromosome rather than two. The most common include:
Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
NIPT can also detect some sex chromosome abnormalities. Its screening accuracy is up to 99% for Down syndrome, 97% for trisomy 18, and 87% for trisomy 13. Even so, every positive result requires confirmation with a diagnostic test such as amniocentesis or chorionic villus sampling. These invasive tests carry some risk, so some pregnant women choose not to confirm the result.
Some testing companies also screen for microdeletion syndromes, but these tests are less accurate and have higher false-positive rates, so many parents decline them even when offered.
NIPT can also reveal fetal sex. Tell your doctor in advance if you do not want this information.
Who Is NIPT Suitable For?
NIPT is available to all pregnant women from 10 weeks of pregnancy and is optional. Those at high risk—including women over 35, those with a previous pregnancy affected by a chromosomal abnormality, or those with a positive result on another screening test—are more likely to choose NIPT and are also less likely to receive a false-positive result.
However, NIPT may not be suitable in some situations, including:
Body mass index (BMI) over 30
Pregnancy using donor eggs
Pregnancy using both donor sperm and donor eggs
Use of certain anticoagulants
Multiple pregnancy
NIPT analyzes the small amount of fetal DNA in maternal blood, about 10%-20% of total cfDNA, so maternal physiological factors can affect accuracy. If the result is inconclusive, the patient may choose diagnostic testing or no further action.
What Happens Next?
A positive NIPT result may be distressing for expectant parents. A genetic counselor can provide professional interpretation. Remember that NIPT is a screening test, not a diagnosis, and its result alone is not definitive. Confirmation through diagnostic testing is required before any major decision.
Whether to pursue further testing is a personal choice. Some pregnant women decide against it after fully considering the benefits and risks.
Insurance coverage for NIPT depends on the policy and whether the pregnancy is considered high risk.
Knowledge | Noninvasive Prenatal Testing (NIPT): An Important Step in Prenatal Genetic Screening
Knowledge | Noninvasive Prenatal Testing (NIPT): An Important Step in Prenatal Genetic Screening
Pregnancy often brings many questions and concerns, with the baby’s health among the most important. Noninvasive Prenatal Testing (NIPT) is a simple blood test that screens for potential fetal genetic abnormalities, particularly chromosomal conditions such as Down syndrome. Although widely used, NIPT does not provide a definitive diagnosis, so more medical professionals now call it noninvasive prenatal screening (NIPS).
What Is NIPT?
NIPT is a blood-based test that examines cell-free DNA (cfDNA) in maternal blood. During pregnancy, some of this DNA comes from the fetus and is called cell-free fetal DNA (cffDNA). Scientists analyze these DNA fragments to screen for specific fetal chromosomal abnormalities. Because no invasive procedure is required, the test poses no risk to the pregnant woman or fetus.
What Can NIPT Tell You?
NIPT primarily screens for trisomies, in which a fetus has three copies of a chromosome rather than two. The most common include:
Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
NIPT can also detect some sex chromosome abnormalities. Its screening accuracy is up to 99% for Down syndrome, 97% for trisomy 18, and 87% for trisomy 13. Even so, every positive result requires confirmation with a diagnostic test such as amniocentesis or chorionic villus sampling. These invasive tests carry some risk, so some pregnant women choose not to confirm the result.
Some testing companies also screen for microdeletion syndromes, but these tests are less accurate and have higher false-positive rates, so many parents decline them even when offered.
NIPT can also reveal fetal sex. Tell your doctor in advance if you do not want this information.
Who Is NIPT Suitable For?
NIPT is available to all pregnant women from 10 weeks of pregnancy and is optional. Those at high risk—including women over 35, those with a previous pregnancy affected by a chromosomal abnormality, or those with a positive result on another screening test—are more likely to choose NIPT and are also less likely to receive a false-positive result.
However, NIPT may not be suitable in some situations, including:
Body mass index (BMI) over 30
Pregnancy using donor eggs
Pregnancy using both donor sperm and donor eggs
Use of certain anticoagulants
Multiple pregnancy
NIPT analyzes the small amount of fetal DNA in maternal blood, about 10%-20% of total cfDNA, so maternal physiological factors can affect accuracy. If the result is inconclusive, the patient may choose diagnostic testing or no further action.
What Happens Next?
A positive NIPT result may be distressing for expectant parents. A genetic counselor can provide professional interpretation. Remember that NIPT is a screening test, not a diagnosis, and its result alone is not definitive. Confirmation through diagnostic testing is required before any major decision.
Whether to pursue further testing is a personal choice. Some pregnant women decide against it after fully considering the benefits and risks.
Insurance coverage for NIPT depends on the policy and whether the pregnancy is considered high risk.
Story source:
Collected online